{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:06:18Z","timestamp":1784297178486,"version":"3.55.0"},"reference-count":259,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018627","name":"Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China","doi-asserted-by":"publisher","award":["2025KJJ025"],"award-info":[{"award-number":["2025KJJ025"]}],"id":[{"id":"10.13039\/501100018627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2025QC815"],"award-info":[{"award-number":["ZR2025QC815"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82501252"],"award-info":[{"award-number":["82501252"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.exer.2026.111096","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T23:54:25Z","timestamp":1780012465000},"page":"111096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Precision management of autoimmune ocular complications: Th17 mechanisms and therapeutic innovations"],"prefix":"10.1016","volume":"270","author":[{"given":"Hongyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1815-5399","authenticated-orcid":false,"given":"Xinwei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.exer.2026.111096_bib1","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/s41433-025-03845-8","article-title":"Comparative efficacy and safety of rituximab, tocilizumab, and teprotumumab in Graves' orbitopathy: a systematic review and meta-analysis","volume":"39","author":"Abumohssin","year":"2025","journal-title":"Eye (Lond)"},{"issue":"9","key":"10.1016\/j.exer.2026.111096_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092525","article-title":"A comprehensive update on retinal vasculitis: etiologies, manifestations and treatments","volume":"11","author":"Agarwal","year":"2022","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2025.102588","article-title":"Clinical efficacy of induced epiphora by punctal plugging on refractory dry eye disease with ocular surface damage: randomized sham-controlled trial","volume":"49","author":"Ahn","year":"2026","journal-title":"Contact Lens Anterior Eye"},{"issue":"8","key":"10.1016\/j.exer.2026.111096_bib4","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41433-022-02216-x","article-title":"Long term complications and vision loss in HLA-B27 uveitis","volume":"37","author":"Al-Ani","year":"2023","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12969-023-00794-y","article-title":"Outcome of adalimumab monotherapy in paediatric non-infectious uveitis","volume":"21","author":"Al-Julandani","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12348-025-00537-y","article-title":"JAK inhibitors in autoimmune ocular inflammatory diseases - a systematic review of case reports and series","volume":"15","author":"Almerri","year":"2025","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"4","key":"10.1016\/j.exer.2026.111096_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043694","article-title":"Tear film MicroRNAs as potential biomarkers: a review","volume":"24","author":"Altman","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2026.111096_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102355","article-title":"In systemic lupus erythematosus anti-dsDNA antibodies can promote thrombosis through direct platelet activation","volume":"107","author":"Andrianova","year":"2020","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12348-018-0156-5","article-title":"Discovery of tear biomarkers in children with chronic non-infectious anterior uveitis: a pilot study","volume":"8","author":"Angeles-Han","year":"2018","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/art.42683","article-title":"Multimodal single-cell sequencing of B cells in primary Sj\u00f6gren's syndrome","volume":"76","author":"Arvidsson","year":"2024","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.exer.2026.111096_bib11","article-title":"Bilateral retinal vasculitis in systemic lupus erythematosus: a case series of three patients","volume":"17","author":"Azad","year":"2025","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13063-023-07087-5","article-title":"A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren's syndrome patients","volume":"24","author":"Bai","year":"2023","journal-title":"Trials"},{"issue":"8","key":"10.1016\/j.exer.2026.111096_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41584-024-01135-3","article-title":"Update on the pathophysiology and treatment of primary Sj\u00f6gren syndrome","volume":"20","author":"Baldini","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.exer.2026.111096_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104662","article-title":"Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials","volume":"93","author":"Bar-Or","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.exer.2026.111096_bib15","article-title":"Evaluation of clinical and ocular surface changes in thyroid eye disease: impact of treatment and risk factors","volume":"17","author":"Barman Kakil","year":"2025","journal-title":"Ther Adv Ophthalmol"},{"issue":"4","key":"10.1016\/j.exer.2026.111096_bib16","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/art.42788","article-title":"Incidence of uveitis in patients with axial spondylarthritis treated with biologics or targeted synthetics: a systematic review and network meta-analysis","volume":"76","author":"Bechman","year":"2024","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.exer.2026.111096_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jtos.2024.03.011","article-title":"Comparative analysis of human tear fluid and aqueous humor proteomes","volume":"33","author":"Beisel","year":"2024","journal-title":"Ocul. Surf."},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/jamaophthalmol.2022.5584","article-title":"Antidrug antibodies to tumor necrosis factor \u03b1 inhibitors in patients with noninfectious uveitis","volume":"141","author":"Bellur","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib20","doi-asserted-by":"crossref","DOI":"10.5935\/0004-2749.2022-0192","article-title":"20% autologous serum vs. 0.05% cyclosporine and preservative-free artificial tears in the treatment of Sj\u00f6gren related dry eye","volume":"87","author":"Berhuni","year":"2022","journal-title":"Arq. Bras. Oftalmol."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12886-020-01769-3","article-title":"Health system wide \"big data\" analysis of rheumatologic conditions and scleritis","volume":"21","author":"Berkenstock","year":"2021","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.exer.2026.111096_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2024.152480","article-title":"Role of F-18 FDG PET-CT in neuropsychiatric systemic lupus erythematosus","volume":"132","author":"Berndorfler","year":"2024","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.exer.2026.111096_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109304","article-title":"Microbiome in Behcet's syndrome","volume":"250","author":"Bettiol","year":"2023","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/joim.13032","article-title":"Environmental factors in the pathogenesis of primary Sj\u00f6gren's syndrome","volume":"287","author":"Bj\u00f6rk","year":"2020","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41433-023-02725-3","article-title":"Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes","volume":"38","author":"Bober","year":"2024","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib26","doi-asserted-by":"crossref","first-page":"Np17","DOI":"10.1177\/11206721241295298","article-title":"Avacopan in the treatment of refractory scleritis secondary to granulomatosis with polyangiitis: a case report","volume":"35","author":"Bober","year":"2025","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111096_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00358","article-title":"Cytokine profiling in aqueous humor samples from patients with non-infectious uveitis associated with systemic inflammatory diseases","volume":"11","author":"Bonacini","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib28","first-page":"107","article-title":"OCT and OCT-A biomarkers in multiple sclerosis - review","volume":"67","author":"Bostan","year":"2023","journal-title":"Rom J Ophthalmol"},{"key":"10.1016\/j.exer.2026.111096_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1632531","article-title":"Current concepts of tocilizumab efficacy in active moderate-to-severe corticosteroid-resistant cases of Graves' orbitopathy","volume":"16","author":"Boutzios","year":"2025","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230560","article-title":"Impact of systemic treatments on the course of HLA-B27-associated uveitis: a retrospective study of 101 patients","volume":"15","author":"Bouzid","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.exer.2026.111096_bib31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/09273948.2023.2191712","article-title":"Therapeutic outcomes of non-infectious scleritis treated with tumor necrosis factor-alpha inhibitors","volume":"32","author":"Brown","year":"2024","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"6","key":"10.1016\/j.exer.2026.111096_bib32","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1177\/11206721221088259","article-title":"Dry eye disease, a prominent manifestation of systemic autoimmune disorders","volume":"32","author":"Bustamante-Arias","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030766","article-title":"Perspectives of therapeutic drug monitoring of biological agents in non-infectious uveitis treatment: a review","volume":"15","author":"Busto-Iglesias","year":"2023","journal-title":"Pharmaceutics"},{"issue":"13","key":"10.1016\/j.exer.2026.111096_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12134448","article-title":"Ocular involvement of granulomatosis with polyangiitis","volume":"12","author":"Byszewska","year":"2023","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.exer.2026.111096_bib35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/children8080646","article-title":"Juvenile idiopathic arthritis associated uveitis","volume":"8","author":"Carlsson","year":"2021","journal-title":"Children"},{"issue":"13","key":"10.1016\/j.exer.2026.111096_bib36","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1177\/09612033241287594","article-title":"JAK inhibitors in systemic lupus erythematosus: translating pathogenesis into therapy","volume":"33","author":"Ceobanu","year":"2024","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/endrev\/bnac017","article-title":"Estrogen receptor signaling in the immune system","volume":"44","author":"Chakraborty","year":"2023","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/ard-2022-222259","article-title":"Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL surveillance","volume":"82","author":"Charles-Schoeman","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.exer.2026.111096_bib39","article-title":"Update on non-infectious uveitis treatment: anti-tnf-alpha and beyond","volume":"4","author":"Chauhan","year":"2024","journal-title":"Front Ophthalmol (Lausanne)"},{"issue":"10","key":"10.1016\/j.exer.2026.111096_bib40","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00296-023-05365-8","article-title":"Bilateral central retinal artery occlusion as a presenting manifestation of systemic lupus erythematosus: a case-based review","volume":"43","author":"Chen","year":"2023","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib41","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ophtha.2023.12.034","article-title":"Use of anterior chamber paracentesis for diagnosis in viral anterior uveitis","volume":"131","author":"Chen","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2026.111096_bib42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ajo.2025.05.017","article-title":"Practice patterns, diagnostic utility, and safety of anterior chamber paracentesis","volume":"277","author":"Choo","year":"2025","journal-title":"Am. J. Ophthalmol."},{"issue":"10","key":"10.1016\/j.exer.2026.111096_bib43","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1080\/09273948.2025.2495826","article-title":"Long-term effects of adalimumab in juvenile idiopathic arthritis-associated uveitis: 3- and 6-Year results of the ADJUVITE trial","volume":"33","author":"Chung","year":"2025","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"9","key":"10.1016\/j.exer.2026.111096_bib44","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.3390\/cimb44090272","article-title":"Optic neuritis in multiple Sclerosis-A review of molecular mechanisms involved in the degenerative process","volume":"44","author":"Ciap\u0103","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/tvst.14.5.31","article-title":"Novel artificial intelligence-based quantification of anterior chamber inflammation using vision transformers","volume":"14","author":"Cifuentes-Gonz\u00e1lez","year":"2025","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"9","key":"10.1016\/j.exer.2026.111096_bib47","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.2967\/jnumed.116.187161","article-title":"(11)C-PBR28 and (18)F-PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis","volume":"58","author":"Datta","year":"2017","journal-title":"J. Nucl. Med."},{"issue":"12","key":"10.1016\/j.exer.2026.111096_bib48","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214408","article-title":"Disability worsening phenotypes in multiple sclerosis and impact of disease-modifying treatments","volume":"105","author":"De Meo","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.exer.2026.111096_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1004795","article-title":"Anti-CD20 therapies in multiple sclerosis: from pathology to the clinic","volume":"14","author":"de S\u00e8ze","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2026.111096_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.151955","article-title":"Long-term abatacept treatment for 48 weeks in patients with primary Sj\u00f6gren's syndrome: the open-label extension phase of the ASAP-III trial","volume":"53","author":"de Wolff","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.exer.2026.111096_bib51","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/IAE.0000000000003838","article-title":"Retinal vasculitis severity assessment: intraobserver and interobserver reliability of a new scheme for grading wide-field fluorescein angiograms in retinal vasculitis","volume":"43","author":"Dhirachaikulpanich","year":"2023","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12348-023-00327-4","article-title":"A systematic review of OCT and OCT angiography in retinal vasculitis","volume":"13","author":"Dhirachaikulpanich","year":"2023","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib53","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ophtha.2017.11.017","article-title":"Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for UveitiS (FOCUS) initiative","volume":"125","author":"Dick","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2026.111096_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.945762","article-title":"Sex bias in lymphocytes: implications for autoimmune diseases","volume":"13","author":"Dodd","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.exer.2026.111096_bib55","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib56","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/APO.0000000000000341","article-title":"Current approach for the diagnosis and management of noninfective scleritis","volume":"10","author":"Dutta Majumder","year":"2020","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"9","key":"10.1016\/j.exer.2026.111096_bib57","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.imbio.2011.03.007","article-title":"CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis","volume":"216","author":"El-Asrar","year":"2011","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib58","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/09273948.2018.1511810","article-title":"The presence of uveitis is associated with a sustained response to the interleukin (IL)-1 inhibitors anakinra and canakinumab in Beh\u00e7et's disease","volume":"28","author":"Fabiani","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib59","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1016\/S2665-9913(24)00035-3","article-title":"Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis","volume":"6","author":"Falde","year":"2024","journal-title":"Lancet Rheumatol."},{"issue":"42","key":"10.1016\/j.exer.2026.111096_bib60","doi-asserted-by":"crossref","first-page":"eadh4655","DOI":"10.1126\/sciadv.adh4655","article-title":"Global lactylome reveals lactylation-dependent mechanisms underlying T(H)17 differentiation in experimental autoimmune uveitis","volume":"9","author":"Fan","year":"2023","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib61","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.survophthal.2024.04.007","article-title":"Optical coherence tomography angiography measurements in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"69","author":"Fekrazad","year":"2024","journal-title":"Surv. Ophthalmol."},{"issue":"10","key":"10.1016\/j.exer.2026.111096_bib62","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1097\/IAE.0000000000003891","article-title":"Optical coherence tomography angiography biomarkers and microperimetry features in BEH\u00c7ET'S uveitis","volume":"43","author":"Ferreira","year":"2023","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib63","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/acr.24963","article-title":"New and updated recommendations for the treatment of juvenile idiopathic arthritis-associated uveitis and idiopathic chronic anterior uveitis","volume":"75","author":"Foeldvari","year":"2023","journal-title":"Arthritis Care Res."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib64","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/bjo-2023-324406","article-title":"A practical approach to uveitis screening in children with juvenile idiopathic arthritis","volume":"109","author":"Foeldvari","year":"2025","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111096_bib65","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2018.02.019","article-title":"Autoimmunity, autoinflammation, and infection in uveitis","volume":"189","author":"Forrester","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111096_bib66","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jtos.2025.05.005","article-title":"The ocular surface tear film as a biomarker for systemic health","volume":"37","author":"Fotovat-Ahmadi","year":"2025","journal-title":"Ocul. Surf."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/joim.13557","article-title":"Systemic lupus erythematosus and cardiovascular disease","volume":"293","author":"Frosteg\u00e5rd","year":"2023","journal-title":"J. Intern. Med."},{"issue":"10","key":"10.1016\/j.exer.2026.111096_bib68","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaneurol.2023.2974","article-title":"Rapid immunodot AQP4 assay for neuromyelitis optica spectrum disorder","volume":"80","author":"Fu","year":"2023","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.exer.2026.111096_bib69","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1093\/rheumatology\/keae359","article-title":"Avacopan for anti-neutrophil cytoplasm antibodies-associated vasculitis: a multicentre real-world study","volume":"64","author":"Gabilan","year":"2025","journal-title":"Rheumatology"},{"issue":"23","key":"10.1016\/j.exer.2026.111096_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11237034","article-title":"Tear and plasma levels of cytokines in patients with uveitis: search for active disease biomarkers","volume":"11","author":"Garc\u00eda-Onrubia","year":"2022","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib71","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1038\/s41467-023-43036-1","article-title":"A large meta-analysis identifies genes associated with anterior uveitis","volume":"14","author":"Gelfman","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib72","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12974-024-03123-6","article-title":"Decoding Behcet's uveitis: an In-depth review of pathogenesis and therapeutic advances","volume":"21","author":"Guan","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"11","key":"10.1016\/j.exer.2026.111096_bib73","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1007\/s10072-021-05127-z","article-title":"Long-term comparative analysis of no evidence of disease activity (NEDA-3) status between multiple sclerosis patients treated with natalizumab and fingolimod for up to 4 years","volume":"42","author":"Guerra","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.exer.2026.111096_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106546","article-title":"TSPO PET in multiple sclerosis: emerging insights into pathophysiology, prognosis, and treatment monitoring","volume":"100","author":"Guido","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.exer.2026.111096_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1407754","article-title":"Applications of Raman spectroscopy in ocular biofluid detection","volume":"12","author":"Guo","year":"2024","journal-title":"Front. Chem."},{"issue":"8","key":"10.1016\/j.exer.2026.111096_bib77","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/ard-2023-224842","article-title":"Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sj\u00f6gren's disease","volume":"83","author":"Gupta","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib76","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.survophthal.2021.08.010","article-title":"Thinking inside the box: current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease","volume":"67","author":"Gupta","year":"2022","journal-title":"Surv. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib78","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12974-018-1352-9","article-title":"In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [(18)F]DPA714 PET","volume":"15","author":"Hagens","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib79","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1186\/s12967-025-07352-y","article-title":"Immunogenicity of adalimumab in patients with noninfectious uveitis based on therapeutic drug monitoring","volume":"23","author":"Han","year":"2025","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.exer.2026.111096_bib80","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1055\/s-0042-121315","article-title":"Necrotising scleritis and peripheral ulcerative keratitis associated with rheumatoid arthritis treated with rituximab","volume":"234","author":"Hardy","year":"2017","journal-title":"Klin Monbl Augenheilkd"},{"issue":"9","key":"10.1016\/j.exer.2026.111096_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094487","article-title":"Therapeutic potential of exosomes derived from adipose tissue-sourced mesenchymal stem cells in the treatment of neural and retinal diseases","volume":"23","author":"Harrell","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib82","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12886-025-04050-7","article-title":"Correlation among ocular surface changes and systemic hematologic indexes and disease activity in primary Sj\u00f6gren\u2019s syndrome: a cross-sectional study","volume":"25","author":"He","year":"2025","journal-title":"BMC Ophthalmol."},{"issue":"19","key":"10.1016\/j.exer.2026.111096_bib83","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.182616","article-title":"IL-23 drives uveitis by acting on a population of tissue-resident entheseal T cells","volume":"10","author":"Hedley","year":"2025","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib84","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ecl.2021.12.004","article-title":"Update on clinical management of graves disease and thyroid eye disease","volume":"51","author":"Hoang","year":"2022","journal-title":"Endocrinol Metab. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.exer.2026.111096_bib85","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmet.2022.02.015","article-title":"The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming","volume":"34","author":"Hochrein","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.exer.2026.111096_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100965","article-title":"Artificial intelligence in OCT angiography","volume":"85","author":"Hormel","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib86","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.21037\/qims-20-730","article-title":"Artifacts and artifact removal in optical coherence tomographic angiography","volume":"11","author":"Hormel","year":"2021","journal-title":"Quant. Imag. Med. Surg."},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib88","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4049\/jimmunol.2100803","article-title":"Analysis of gene expression and TCR\/B cell receptor profiling of immune cells in primary Sj\u00f6gren's syndrome by single-cell sequencing","volume":"209","author":"Hou","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.exer.2026.111096_bib91","article-title":"Multidimensional immunotherapy for dry eye disease: current status and future directions","volume":"4","author":"Huang","year":"2024","journal-title":"Front Ophthalmol (Lausanne)"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261242","article-title":"Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: an integrated single-cell analysis","volume":"17","author":"Huang","year":"2022","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.exer.2026.111096_bib90","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.64.12.28","article-title":"Therapeutic effects of upadacitinib on experimental autoimmune uveitis: insights from single-cell analysis","volume":"64","author":"Huang","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"10271","key":"10.1016\/j.exer.2026.111096_bib92","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(20)32341-2","article-title":"Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial","volume":"397","author":"Humby","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/children10030434","article-title":"Tocilizumab in juvenile idiopathic arthritis associated uveitis, a narrative review","volume":"10","author":"Iannone","year":"2023","journal-title":"Children"},{"key":"10.1016\/j.exer.2026.111096_bib94","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ajo.2023.06.023","article-title":"Cataract surgery in patients with uveitis treated with systemic therapy in the multicenter uveitis steroid treatment (MUST) trial and Follow-up study: risk factors and outcomes","volume":"254","author":"Jabs","year":"2023","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2024.105697","article-title":"Targeted therapies for uveitis in spondyloarthritis: a narrative review","volume":"91","author":"Jacquot","year":"2024","journal-title":"Jt. Bone Spine"},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib96","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41433-024-03530-2","article-title":"Neural networks for predicting etiological diagnosis of uveitis","volume":"39","author":"Jacquot","year":"2025","journal-title":"Eye"},{"issue":"11","key":"10.1016\/j.exer.2026.111096_bib97","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ajpath.2023.03.004","article-title":"The microbiome and uveitis: a narrative review","volume":"193","author":"Janetos","year":"2023","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.exer.2026.111096_bib98","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231187933","article-title":"Optical coherence tomography angiography: a review of the current literature","volume":"51","author":"Javed","year":"2023","journal-title":"J. Int. Med. Res."},{"issue":"7","key":"10.1016\/j.exer.2026.111096_bib99","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib100","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41467-025-68264-5","article-title":"Altered B cell activation contributes to the immunopathogenesis of childhood arthritis-associated uveitis","volume":"17","author":"Jebson","year":"2026","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib101","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/rheumatology\/keaa624","article-title":"Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sj\u00f6gren's syndrome","volume":"60","author":"Jimenez-Royo","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.exer.2026.111096_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1646850","article-title":"Case report: concurrent retinal vasculitis and optic neuritis in systemic lupus erythematosus","volume":"16","author":"Jin","year":"2025","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.exer.2026.111096_bib103","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/01676830.2021.1939726","article-title":"Acute orbital inflammation with loss of vision: a paradoxical adverse event associated with infliximab therapy for Crohn's disease","volume":"41","author":"Jordan","year":"2022","journal-title":"Orbit"},{"issue":"11","key":"10.1016\/j.exer.2026.111096_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12113648","article-title":"Beh\u00e7et's disease uveitis","volume":"12","author":"Joubert","year":"2023","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.exer.2026.111096_bib105","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.revmed.2023.06.004","article-title":"Beh\u00e7et's disease uveitis","volume":"44","author":"Joubert","year":"2023","journal-title":"Rev Med Interne"},{"issue":"7","key":"10.1016\/j.exer.2026.111096_bib106","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/rheumatology\/keac663","article-title":"Ocular manifestations of ANCA-associated vasculitis","volume":"62","author":"Junek","year":"2023","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.exer.2026.111096_bib107","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1210\/clinem\/dgad381","article-title":"Proof-of-concept and randomized, placebo-controlled trials of an FcRn inhibitor, batoclimab, for thyroid eye disease","volume":"108","author":"Kahaly","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.exer.2026.111096_bib108","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1089\/thy.2023.0656","article-title":"Long-term efficacy of teprotumumab in thyroid eye disease: follow-up outcomes in three clinical trials","volume":"34","author":"Kahaly","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/j.exer.2026.111096_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1694311","article-title":"Effectiveness and safety of tocilizumab in refractory noninfectious uveitis: a systematic review and meta-analysis","volume":"16","author":"Kang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.exer.2026.111096_bib110","article-title":"The current and novel imaging modalities for ocular vasculitis in Behcet's disease: a review","volume":"16","author":"Kaur","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib111","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12886-025-04155-z","article-title":"Efficacy of mini-scleral lenses in visual rehabilitation for corneal disorders: a prospective study","volume":"25","author":"Kaushik","year":"2025","journal-title":"BMC Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib112","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s42003-025-08115-7","article-title":"Single-cell multiomic analysis unveils the immune landscape dynamics of graves' ophthalmopathy","volume":"8","author":"Ke","year":"2025","journal-title":"Commun. Biol."},{"issue":"24","key":"10.1016\/j.exer.2026.111096_bib114","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.182352","article-title":"Transcriptomic profiling of thyroid eye disease orbital fat demonstrates differences in adipogenicity and IGF-1R pathway","volume":"9","author":"Kim","year":"2024","journal-title":"JCI Insight"},{"issue":"14","key":"10.1016\/j.exer.2026.111096_bib113","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1167\/iovs.19-27062","article-title":"Comparison of MicroRNA expression in tears of normal subjects and sj\u00f6gren syndrome patients","volume":"60","author":"Kim","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111096_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.624971","article-title":"Current insights and future prospects for targeting IL-17 to treat patients with systemic lupus erythematosus","volume":"11","author":"Koga","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib116","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3341\/kjo.2019.0145","article-title":"Tear osmolarity and matrix Metallopeptidase-9 in dry eye associated with Sj\u00f6gren's syndrome","volume":"34","author":"Kook","year":"2020","journal-title":"Kor. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.exer.2026.111096_bib117","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1136\/ard-2023-225319","article-title":"Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations","volume":"83","author":"Kostopoulou","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.exer.2026.111096_bib118","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1007\/s00415-023-11920-x","article-title":"An update on optic neuritis","volume":"270","author":"Kraker","year":"2023","journal-title":"J. Neurol."},{"issue":"21","key":"10.1016\/j.exer.2026.111096_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111628","article-title":"A comprehensive review of thyroid eye disease pathogenesis: from immune dysregulations to novel diagnostic and therapeutic approaches","volume":"25","author":"Kulbay","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.exer.2026.111096_bib120","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/09273948.2020.1828937","article-title":"Systemic lupus erythematosus-associated retinal vasculitis treated with adalimumab","volume":"30","author":"Kuthyar","year":"2022","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13030912","article-title":"Comparison of incidence or recurrence of anterior uveitis in patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors","volume":"13","author":"Kwon","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exer.2026.111096_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109318","article-title":"Neutrophil, NETs and Beh\u00e7et's disease: a review","volume":"250","author":"Le Joncour","year":"2023","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.exer.2026.111096_bib123","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/ICU.0000000000000810","article-title":"Update on ophthalmic manifestations of systemic lupus erythematosus: pathogenesis and precision medicine","volume":"32","author":"Lee","year":"2021","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib124","first-page":"999","article-title":"Prognostic signature of interferon-\u03b3 and interleurkin-17A in early rheumatoid arthritis","volume":"40","author":"Lee","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5414\/CP204053","volume":"60","author":"Lee","year":"2022","journal-title":"Int. J. Clin. Pharm. Ther."},{"issue":"9","key":"10.1016\/j.exer.2026.111096_bib126","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","article-title":"The complement system in systemic lupus erythematosus: an update","volume":"73","author":"Leffler","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib128","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/s00259-024-07015-y","article-title":"Evaluation of fibroinflammatory activity in thyroid eye disease using [(18)F]AlF-NOTA-FAPI-04 PET\/CT: a prospective study","volume":"52","author":"Li","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"49","key":"10.1016\/j.exer.2026.111096_bib127","article-title":"Tear cytokine levels in Sjogren's syndrome-related dry eye disease compared with non-sjogren's syndrome-related dry eye disease patients: a meta-analysis","volume":"103","author":"Li","year":"2024","journal-title":"Medicine (Baltim.)"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib130","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-026-03778-x","article-title":"Upadacitinib for refractory Behcet's syndrome: a multi-centre, single-arm trial","volume":"28","author":"Li","year":"2026","journal-title":"Arthritis Res. Ther."},{"issue":"14","key":"10.1016\/j.exer.2026.111096_bib129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/iovs.66.14.11","article-title":"High-throughput tear proteomics reveals multi-faceted signatures of thyroid eye disease","volume":"66","author":"Li","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib131","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2026.2625552","article-title":"JAK inhibitor tofacitinib alleviates secretory dysfunction and Th17\/Treg imbalance in a Sj\u00f6gren's disease murine model","volume":"58","author":"Lin","year":"2026","journal-title":"Ann. Med."},{"key":"10.1016\/j.exer.2026.111096_bib133","article-title":"Gut microbiome dysregulation in noninfectious uveitis","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.exer.2026.111096_bib134","doi-asserted-by":"crossref","DOI":"10.1002\/kjm2.12938","article-title":"Antithrombotic use in retinal artery occlusion: a narrative review","volume":"41","author":"Liu","year":"2025","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"22","key":"10.1016\/j.exer.2026.111096_bib132","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.181488","article-title":"Dynamic transition of tregs to cytotoxic phenotype amid systemic inflammation in Graves' ophthalmopathy","volume":"9","author":"Liu","year":"2024","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.exer.2026.111096_bib135","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10067-017-3672-z","article-title":"IL-6 blockade in the management of non-infectious uveitis","volume":"36","author":"Lopalco","year":"2017","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.exer.2026.111096_bib136","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.18240\/ijo.2022.06.25","article-title":"Combined central retinal artery and vein occlusion associated with primary antiphospholipid syndrome treated by injection of dexamethasone intravitreal implant and anticoagulant therapy: a case report","volume":"15","author":"Lu","year":"2022","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111096_bib137","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/OPTO.S492202","article-title":"Drug-induced uveitis: patterns, pathogenesis and clinical implications","volume":"17","author":"Lu","year":"2025","journal-title":"Clin. Optom."},{"issue":"20","key":"10.1016\/j.exer.2026.111096_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012264","article-title":"Understanding ocular findings and manifestations of systemic lupus erythematosus: update review of the literature","volume":"23","author":"Lubo\u0144","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib139","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12348-024-00394-1","article-title":"Peripheral ulcerative keratitis associated with tralokinumab therapy: a case report and review of IL-13 inhibitor-associated ocular surface disease","volume":"14","author":"Maganti","year":"2024","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/08830185.2020.1851372","article-title":"A comprehensive overview on the genetics of Beh\u00e7et's disease","volume":"41","author":"Mahmoudi","year":"2022","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.exer.2026.111096_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175025","article-title":"Dimethyl fumarate: a review of preclinical efficacy in models of neurodegenerative diseases","volume":"926","author":"Majkutewicz","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib142","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13550-023-00964-9","article-title":"[(18)F] FDG uptake in patients with spondyloarthritis: correlation with serum inflammatory biomarker levels","volume":"13","author":"Manabe","year":"2023","journal-title":"EJNMMI Res."},{"issue":"23","key":"10.1016\/j.exer.2026.111096_bib143","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186520","article-title":"Sex, cells, and metabolism: androgens temper Th17-mediated immunity","volume":"134","author":"Mani","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"23","key":"10.1016\/j.exer.2026.111096_bib144","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163030","article-title":"A randomized, phase II study of sequential belimumab and rituximab in primary Sj\u00f6gren's syndrome","volume":"7","author":"Mariette","year":"2022","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.exer.2026.111096_bib145","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.exer.2026.111096_bib146","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.exer.2026.111096_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1395609","article-title":"Ocular fundus changes and association with systemic conditions in systemic lupus erythematosus","volume":"15","author":"Meng","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2026.111096_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1340224","article-title":"Quantitative assessment of retinal vasculature changes in systemic lupus erythematosus using wide-field OCTA and the correlation with disease activity","volume":"15","author":"Meng","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib149","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1893888","article-title":"Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo","volume":"13","author":"Mester","year":"2021","journal-title":"mAbs"},{"key":"10.1016\/j.exer.2026.111096_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109274","article-title":"Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitis","volume":"249","author":"Michailidou","year":"2023","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/biology14030275","article-title":"The role of Th17\/Treg axis in retinal pathology associated with diabetes and treatment options","volume":"14","author":"Mickael","year":"2025","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib152","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib153","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10067-019-04875-w","article-title":"JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis","volume":"39","author":"Miserocchi","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.exer.2026.111096_bib157","article-title":"Immune privilege: the microbiome and uveitis","volume":"11","author":"M\u00f6lzer","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib154","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1120672121992680","article-title":"Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to Sjogren syndrome","volume":"32","author":"Moawad","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib155","first-page":"214","article-title":"Ocular and orbital manifestations of granulomatosis with polyangiitis: a systematic review of published cases","volume":"67","author":"Moin","year":"2023","journal-title":"Rom J Ophthalmol"},{"issue":"8","key":"10.1016\/j.exer.2026.111096_bib156","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41433-024-02967-9","article-title":"The changing landscape of thyroid eye disease: current clinical advances and future outlook","volume":"38","author":"Moledina","year":"2024","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib158","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12974-024-03109-4","article-title":"The gut microbiome and HLA-B27-associated anterior uveitis: a case-control study","volume":"21","author":"Morandi","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.exer.2026.111096_bib159","doi-asserted-by":"crossref","first-page":"bvae182","DOI":"10.1210\/jendso\/bvae182","article-title":"The TSH receptor antibody reactome contributes to retro-orbital inflammation","volume":"8","author":"Morshed","year":"2024","journal-title":"J. Endocr. Soc."},{"issue":"11","key":"10.1016\/j.exer.2026.111096_bib160","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/acn3.51632","article-title":"Prior optic neuritis detection on peripapillary ring scans using deep learning","volume":"9","author":"Motamedi","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.exer.2026.111096_bib161","doi-asserted-by":"crossref","first-page":"37","DOI":"10.31138\/mjr.231123.jia","article-title":"JAK inhibition as a potential treatment target in systemic lupus erythematosus","volume":"35","author":"Moysidou","year":"2024","journal-title":"Mediterr J Rheumatol"},{"issue":"7","key":"10.1016\/j.exer.2026.111096_bib162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0323192","article-title":"OCTA measurements in Behcet's disease across different stages of the disease activity: a systematic review and meta-analysis","volume":"20","author":"Mozafar","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2026.111096_bib163","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.2147\/OPTH.S495307","article-title":"Artificial intelligence in uveitis: innovations in diagnosis and therapeutic strategies","volume":"18","author":"Murugan","year":"2024","journal-title":"Clin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib164","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12030530","article-title":"Antiphospholipid antibodies are major risk factors for non-thrombotic cardiac complications in systemic lupus erythematosus","volume":"12","author":"Nagy","year":"2024","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.exer.2026.111096_bib165","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/art.42540","article-title":"Lysosome-associated membrane protein 3 induces lysosome-dependent cell death by impairing autophagic caspase 8 degradation in the salivary glands of individuals with Sj\u00f6gren's disease","volume":"75","author":"Nakamura","year":"2023","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib166","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282227","article-title":"Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sj\u00f6gren's disease","volume":"18","author":"Nakamura","year":"2023","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.exer.2026.111096_bib167","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/art.42844","article-title":"Amplified type I interferon response in Sj\u00f6gren's disease via ectopic toll-like receptor 7 expression in salivary gland epithelial cells induced by lysosome-associated membrane protein 3","volume":"76","author":"Nakamura","year":"2024","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.exer.2026.111096_bib168","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.survophthal.2023.02.007","article-title":"Artificial intelligence in uveitis: a comprehensive review","volume":"68","author":"Nakayama","year":"2023","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111096_bib169","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ajo.2023.01.020","article-title":"Smoking is associated with a higher risk of surgical intervention for thyroid eye disease in the IRIS registry","volume":"249","author":"Oke","year":"2023","journal-title":"Am. J. Ophthalmol."},{"issue":"12","key":"10.1016\/j.exer.2026.111096_bib170","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11121547","article-title":"The double game played by Th17 cells in infection: host defense and immunopathology","volume":"11","author":"Paroli","year":"2022","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib171","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tim.2022.08.008","article-title":"The microbiome in HLA-B27-associated disease: implications for acute anterior uveitis and recommendations for future studies","volume":"31","author":"Parthasarathy","year":"2023","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.exer.2026.111096_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103160","article-title":"Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis","volume":"143","author":"Peng","year":"2024","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.exer.2026.111096_bib173","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/acr2.11466","article-title":"Predicting sustained clinical response to rituximab in moderate to severe systemic manifestations of primary sj\u00f6gren syndrome","volume":"4","author":"Pepple","year":"2022","journal-title":"ACR Open Rheumatol."},{"issue":"10","key":"10.1016\/j.exer.2026.111096_bib174","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","article-title":"Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis","volume":"16","author":"Petzold","year":"2017","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12348-023-00352-3","article-title":"Clinical characterization of patients with HLA-B27-associated uveitis and evaluation of the impact of systemic treatment on the recurrence rate: a cross-sectional study","volume":"13","author":"Pineda-Sierra","year":"2023","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"10","key":"10.1016\/j.exer.2026.111096_bib176","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10102118","article-title":"Rheumatoid arthritis associated episcleritis and scleritis: an update on treatment perspectives","volume":"10","author":"Promelle","year":"2021","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.exer.2026.111096_bib177","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4103\/IJO.IJO_61_25","article-title":"JAK-STAT inhibitors in noninfectious uveitis - a review","volume":"73","author":"Pyare","year":"2025","journal-title":"Indian J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.exer.2026.111096_bib178","doi-asserted-by":"crossref","DOI":"10.1177\/20542704211062041","article-title":"Massive haemorrhage: an unusual presentation of systemic lupus erythematosus","volume":"12","author":"Qayyum","year":"2021","journal-title":"JRSM Open"},{"key":"10.1016\/j.exer.2026.111096_bib179","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20951733","article-title":"Uveitis in spondyloarthritis","volume":"12","author":"Rademacher","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib180","first-page":"23","article-title":"Effect of vitamin A on recovery from the acute phase of multiple sclerosis-related optic neuritis, double-blind, randomized, placebo-controlled trial","volume":"14","author":"Rahimi-Dehgolan","year":"2023","journal-title":"Caspian J Intern Med"},{"issue":"17","key":"10.1016\/j.exer.2026.111096_bib181","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","article-title":"Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis","volume":"376","author":"Ramanan","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib182","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.exer.2026.111096_bib183","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/ICU.0000000000000890","article-title":"Ocular manifestations of rheumatoid arthritis","volume":"33","author":"Reddy","year":"2022","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib184","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12348-024-00386-1","article-title":"Risk factors for failing sub-tenon's triamcinolone acetonide for uveitic macular edema","volume":"14","author":"Reddy","year":"2024","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12014-025-09564-2","article-title":"Proteomics analysis of aqueous and vitreous humor in uveitis: a systematic literature review","volume":"23","author":"Reeg","year":"2025","journal-title":"Clin. Proteom."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib186","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s12886-024-03760-8","article-title":"Evaluation of ocular surface inflammation and systemic conditions in patients with systemic lupus erythematosus: a cross-sectional study","volume":"24","author":"Ren","year":"2024","journal-title":"BMC Ophthalmol."},{"issue":"8","key":"10.1016\/j.exer.2026.111096_bib187","article-title":"The complex roles of macrophages in Sj\u00f6gren's syndrome: a narrative review","volume":"17","author":"Ren","year":"2025","journal-title":"Cureus"},{"issue":"17","key":"10.1016\/j.exer.2026.111096_bib188","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713581","article-title":"The role of neutrophil extracellular traps (NETs) in the pathogenesis of systemic lupus erythematosus and antiphospholipid syndrome","volume":"24","author":"Reshetnyak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib189","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13075-021-02549-0","article-title":"Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials","volume":"23","author":"Roche","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12348-025-00529-y","article-title":"Adalimumab in non-infectious uveitis, towards a real-world therapeutic paradigm beyond inflammation control: a multicenter cross-sectional study","volume":"15","author":"Rodr\u00edguez-Fern\u00e1ndez","year":"2025","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib191","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/jnnp-2023-331920","article-title":"Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS study","volume":"95","author":"Ruggieri","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.exer.2026.111096_bib192","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/bjophthalmol-2022-321132","article-title":"Rheumatoid arthritis-associated peripheral ulcerative keratitis outcomes after early immunosuppressive therapy","volume":"107","author":"Ruiz-Lozano","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111096_bib193","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.2147\/OPTH.S385782","article-title":"Surgical management of peripheral ulcerative keratitis: update on surgical techniques and their outcome","volume":"16","author":"Sabhapandit","year":"2022","journal-title":"Clin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib194","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/00045632241285843","article-title":"Biomarkers in the diagnosis, prognosis and management of rheumatoid arthritis: a comprehensive review","volume":"62","author":"Sahin","year":"2025","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.exer.2026.111096_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2024.106888","article-title":"Dysregulated Th17\/Treg cell axis is correlated with local and systemic immune response in human intermediate uveitis","volume":"268","author":"Saini","year":"2024","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.exer.2026.111096_bib196","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.survophthal.2017.05.006","article-title":"The application of optical coherence tomography angiography in retinal diseases","volume":"62","author":"Sambhav","year":"2017","journal-title":"Surv. Ophthalmol."},{"issue":"4","key":"10.1016\/j.exer.2026.111096_bib198","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-006071","article-title":"Long-term outcomes of JIA-associated uveitis: a systematic review and meta-analysis","volume":"11","author":"Scagnellato","year":"2025","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.exer.2026.111096_bib199","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing immune-mediated inflammatory diseases through signature cytokine hubs","volume":"385","author":"Schett","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s43556-025-00337-9","article-title":"Neutrophil extracellular traps (NETs) in health and disease","volume":"6","author":"Shahzad","year":"2025","journal-title":"Mol Biomed"},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib201","doi-asserted-by":"crossref","DOI":"10.3390\/biom13050724","article-title":"The autoimmune rheumatic disease related dry eye and its association with retinopathy","volume":"13","author":"Shan","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.exer.2026.111096_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156154","article-title":"Translational implications of humoral and cellular immune dysfunction in granulomatosis with polyangiitis","volume":"164","author":"Singh","year":"2023","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12149-023-01896-z","article-title":"Role of PET\/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review","volume":"38","author":"Singh","year":"2024","journal-title":"Ann. Nucl. Med."},{"issue":"18","key":"10.1016\/j.exer.2026.111096_bib204","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.exer.2026.111096_bib197","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092816","article-title":"Anti-IL-6 receptor tocilizumab in refractory graves' orbitopathy: national multicenter observational study of 48 patients","volume":"9","author":"S\u00e1nchez-Bilbao","year":"2020","journal-title":"J. Clin. Med."},{"issue":"9","key":"10.1016\/j.exer.2026.111096_bib205","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamaophthalmol.2024.2439","article-title":"Filgotinib in active noninfectious uveitis: the HUMBOLDT randomized clinical trial","volume":"142","author":"Srivastava","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.exer.2026.111096_bib206","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/09273948.2025.2467435","article-title":"Long-term outcomes of uveoretinitis in Beh\u00e7et's disease in the era of biologic treatments: a 10-Year Follow-Up study","volume":"33","author":"Sugawara","year":"2025","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"24","key":"10.1016\/j.exer.2026.111096_bib207","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12247627","article-title":"Real-world effectiveness of belimumab in patients with active lupus","volume":"12","author":"Sumichika","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exer.2026.111096_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114483","article-title":"T helper 17 (Th17) cell responses to the gut microbiota in human diseases","volume":"161","author":"Sun","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib209","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41927-025-00456-4","article-title":"Efficacy and safety of avacopan in antineutrophil cytoplasmic autoantibody-associated vasculitis: a retrospective cohort study in Japan","volume":"9","author":"Tagami","year":"2025","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.exer.2026.111096_bib210","article-title":"Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Beh\u00e7et's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial","author":"Talarico","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.exer.2026.111096_bib211","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1726690","article-title":"A 20-year real-world study on drug survival and predictive factors for infliximab discontinuation in Beh\u00e7et's syndrome","volume":"16","author":"Talarico","year":"2025","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.exer.2026.111096_bib212","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jaip.2023.04.015","article-title":"The Th17\/IL-17 axis and host defense against fungal infections","volume":"11","author":"Tangye","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.exer.2026.111096_bib213","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221114101","article-title":"Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes","volume":"14","author":"Taylor","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib214","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41584-023-00932-6","article-title":"Genetics and epigenetics of primary Sj\u00f6gren syndrome: implications for future therapies","volume":"19","author":"Thorlacius","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.exer.2026.111096_bib215","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.579438","article-title":"New algorithms improving PML risk stratification in MS patients treated with natalizumab","volume":"11","author":"Toboso","year":"2020","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib216","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/meajo.meajo_132_21","article-title":"Spondyloarthritis associated with uveitis: a review","volume":"30","author":"Toufik","year":"2023","journal-title":"Middle East Afr. J. Ophthalmol."},{"issue":"17","key":"10.1016\/j.exer.2026.111096_bib217","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176401","article-title":"The role of the IL-23\/IL-17 pathway in the pathogenesis of spondyloarthritis","volume":"21","author":"Tsukazaki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib218","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-069338","article-title":"Antimicrobial resistance in topical treatments for microbial keratitis: protocol for a systematic review and meta-analysis","volume":"13","author":"Tuft","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib219","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3899\/jrheum.190768","article-title":"Ocular manifestations in rheumatoid arthritis, connective tissue disease, and vasculitis: a systematic review and metaanalysis","volume":"48","author":"Turk","year":"2021","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.exer.2026.111096_bib220","doi-asserted-by":"crossref","first-page":"rkae090","DOI":"10.1093\/rap\/rkae090","article-title":"Long-term surveillance study of rituximab originator treated patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA)","volume":"8","author":"Uchida","year":"2024","journal-title":"Rheumatol Adv Pract"},{"issue":"6","key":"10.1016\/j.exer.2026.111096_bib221","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1210\/endrev\/bnae018","article-title":"Teprotumumab for the treatment of thyroid eye disease","volume":"45","author":"Ugradar","year":"2024","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.exer.2026.111096_bib222","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/09273948.2022.2126374","article-title":"Efficacy and safety of tocilizumab in the management of non-infectious uveitis failed with conventional immunomodulatory and Anti-TNF\u03b1 therapies","volume":"32","author":"Uludag","year":"2024","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"11","key":"10.1016\/j.exer.2026.111096_bib223","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.oret.2025.05.006","article-title":"Prevalence, treatment patterns, and outcomes of pediatric noninfectious uveitis in the United States: an IRIS registry analysis","volume":"9","author":"Uner","year":"2025","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib224","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S2665-9913(20)30057-6","article-title":"Leflunomide-hydroxychloroquine combination therapy in patients with primary Sj\u00f6gren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial","volume":"2","author":"van der Heijden","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"12","key":"10.1016\/j.exer.2026.111096_bib225","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1093\/rheumatology\/keaa251","article-title":"Leukocyte toll-like receptor expression in pathergy positive and negative Beh\u00e7et's disease patients","volume":"59","author":"van der Houwen","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.exer.2026.111096_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.151956","article-title":"Immunopathogenesis of Beh\u00e7et's disease and treatment modalities","volume":"52","author":"van der Houwen","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"issue":"13","key":"10.1016\/j.exer.2026.111096_bib227","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14134439","article-title":"The future of PET imaging in multiple sclerosis: characterisation of individual white matter lesions","volume":"14","author":"van der Weijden","year":"2025","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.exer.2026.111096_bib228","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1080\/09273948.2023.2278060","article-title":"Uveitis associated with juvenile idiopathic arthritis","volume":"31","author":"van Meerwijk","year":"2023","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib229","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003010","article-title":"Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-na\u00efve juvenile idiopathic arthritis","volume":"9","author":"van Straalen","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.exer.2026.111096_bib230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajo.2018.12.019","article-title":"Anti-IL6-Receptor tocilizumab in refractory and noninfectious uveitic cystoid macular edema: Multicenter study of 25 patients","volume":"200","author":"Vegas-Revenga","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111096_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108078","article-title":"Current insights in the pathogenesis of scleritis","volume":"197","author":"Vergouwen","year":"2020","journal-title":"Exp. Eye Res."},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib232","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1590\/S0004-27492012000500006","article-title":"Radiation therapy for Graves' ophthalmopathy: a systematic review and meta-analysis of randomized controlled trials","volume":"75","author":"Viani","year":"2012","journal-title":"Arq. Bras. Oftalmol."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib233","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11739-022-03117-3","article-title":"The diagnostic role of pathergy test in patients with Beh\u00e7et's disease from the Western Europe","volume":"18","author":"Vitale","year":"2023","journal-title":"Intern. Emerg. Med."},{"issue":"12","key":"10.1016\/j.exer.2026.111096_bib235","doi-asserted-by":"crossref","first-page":"bvae193","DOI":"10.1210\/jendso\/bvae193","article-title":"Efficacy of tocilizumab in refractory graves orbitopathy from real-world clinical practice: an observational study","volume":"8","author":"Wang","year":"2024","journal-title":"J. Endocr. Soc."},{"issue":"20","key":"10.1016\/j.exer.2026.111096_bib234","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13203222","article-title":"Clinical research of lupus retinopathy: quantitative analysis of retinal vessels by optical coherence tomography angiography in patients with systemic lupus erythematosus","volume":"13","author":"Wang","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.exer.2026.111096_bib236","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fimmu.2019.00214","article-title":"B cells as a therapeutic target in paediatric rheumatic disease","volume":"10","author":"Wilkinson","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib237","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021580","article-title":"An overview of the dry eye disease in Sj\u00f6gren's syndrome using our current molecular understanding","volume":"24","author":"Wu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.exer.2026.111096_bib238","article-title":"NETs-CD44-IL-17A feedback loop drives Th17-Mediated inflammation in beh\u00e7et's uveitis","volume":"12","author":"Wu","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"Pt 1","key":"10.1016\/j.exer.2026.111096_bib239","article-title":"Microglia in retinal diseases: from pathogenesis towards therapeutic strategies","volume":"230","author":"Xiao","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib240","doi-asserted-by":"crossref","DOI":"10.48130\/vns-0025-0004","article-title":"Microglial phagocytosis involves hyperoxia-induced vessel regression in the neonatal retina","volume":"42","author":"Xu","year":"2025","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.exer.2026.111096_bib242","article-title":"From promise to practice: evaluating the clinical impact of FcRn inhibition in IgG-mediated autoimmune rheumatic diseases","volume":"16","author":"Yang","year":"2025","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.exer.2026.111096_bib241","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s40264-023-01333-0","article-title":"Managing cardiovascular and cancer risk associated with JAK inhibitors","volume":"46","author":"Yang","year":"2023","journal-title":"Drug Saf."},{"issue":"5","key":"10.1016\/j.exer.2026.111096_bib243","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.autrev.2012.10.006","article-title":"Type I interferons in Sj\u00f6gren's syndrome","volume":"12","author":"Yao","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.exer.2026.111096_bib244","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.exer.2026.111096_bib245","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1210\/clinem\/dgae876","article-title":"CD34+ orbital fibroblasts contribute to the pathogenesis of thyroid eye disease via miR-182-5p","volume":"110","author":"Yu","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.exer.2026.111096_bib246","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00415-025-13224-8","article-title":"Long-term effectiveness and safety of ocrelizumab: a single-centre real-world study","volume":"272","author":"Zaccone","year":"2025","journal-title":"J. Neurol."},{"issue":"21","key":"10.1016\/j.exer.2026.111096_bib247","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10215174","article-title":"Ocular manifestations of Beh\u00e7et's disease: an update on diagnostic challenges and disease management","volume":"10","author":"Zaj\u0105c","year":"2021","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.exer.2026.111096_bib249","first-page":"Cd010968","article-title":"Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis","volume":"11","author":"Zhang","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"10.1016\/j.exer.2026.111096_bib248","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/bjophthalmol-2016-310044","article-title":"Treatment of experimental autoimmune uveoretinitis with intravitreal injection of infliximab encapsulated in liposomes","volume":"101","author":"Zhang","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111096_bib251","article-title":"Anti-endothelial cell antibodies in pathogenesis of vasculitis","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.exer.2026.111096_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31932","article-title":"Efficacy of rituximab in treating steroid-resistant Graves' orbitopathy in active moderate-to-severe and sight-threatening forms: a retrospective observation from China","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.exer.2026.111096_bib252","article-title":"Overview of dendritic cells and related pathways in autoimmune uveitis","volume":"19","author":"Zhao","year":"2024","journal-title":"Open Life Sci."},{"key":"10.1016\/j.exer.2026.111096_bib253","article-title":"Risk of new-onset and recurrent uveitis with different biologics for ankylosing spondylitis: a network meta-analysis","volume":"16","author":"Zhao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2026.111096_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100866","article-title":"Activation of the interleukin-23\/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis","volume":"80","author":"Zhong","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"issue":"4","key":"10.1016\/j.exer.2026.111096_bib255","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/jamaophthalmol.2020.6985","article-title":"Tuberculosis exposure with risk of beh\u00e7et disease among patients with uveitis","volume":"139","author":"Zhong","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib256","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55804","article-title":"Early vs deferred non-messenger RNA COVID-19 vaccination among Chinese patients with a history of inactive uveitis: a randomized clinical trial","volume":"6","author":"Zhong","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib258","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaad.2025.02.081","article-title":"Effect of prednisone plus either adalimumab or cyclosporine on dermatological symptoms in vogt-koyanagi-harada disease: systemic outcomes from a randomized trial","volume":"93","author":"Zhong","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.exer.2026.111096_bib257","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2023.101216","article-title":"Risk factors, clinical features and treatment of Beh\u00e7et's disease uveitis","volume":"97","author":"Zhong","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"issue":"2","key":"10.1016\/j.exer.2026.111096_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166302","article-title":"Plasmacytoid dendritic cells promote the pathogenesis of Sj\u00f6gren's syndrome","volume":"1868","author":"Zhou","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526002526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526002526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:34:40Z","timestamp":1784295280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483526002526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":259,"alternative-id":["S0014483526002526"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2026.111096","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision management of autoimmune ocular complications: Th17 mechanisms and therapeutic innovations","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2026.111096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111096"}}